Bayer reported €3.39B in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Akzo Nobel AKZA:NA € 1216M 19M
Alcon AG ALC:SW 1.37B 198M
Amarin AMRN:US $ 327.02M 36.02M
Arkema AKE:FP € 2415M 921M
AstraZeneca AZN:LN 15567M 7931M
BASF BAS:GR € 2869M 1258M
Bayer BAYN:GR € 3389M 2161M
Corteva Inc CTVA:US $ 2.86B 457M
Covestro 1COV:GR 856M 1.25B
DSM DSM:NA € 871M 815M
Fresenius FRE:GR € 2250M 373M
Fresenius Medical Care FME:GR € 1408M 335M
Genmab GEN:DC DK 9477M 1585M
Givaudan GIVN:VX 306M 105M
GlaxoSmithKline GSK:LN 3503M 1254M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 2M 321M
Johnson Matthey JMAT:LN 581M 189M
Linde LIN:GR € 3137M 959M
Lonza Group LONN:SW 501M 6M
Merck MRK:GR € 1825M 413M
Novartis NOVN:VX SF 5117M 1316M
Philips PHIA:NA € 1003M 37M
Ppg Industries PPG:US $ 1216M 21M
SAP SAP:GR € 7764M 2568M
Solvay SOLB:BB € 1216M 71M
Umicore UMI:BB 1.19B 178.59M